Dupilumab therapy in children aged 2–12 years with uncontrolled moderate‐to‐severe atopic dermatitis: A Chinese real‐world study
Bingjing Zhou, Cong Peng, Qiaozhi Cao, Jiayi Wang, Xiang Chen, Jie Li
Abstract
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Topics & Concepts
Eczema Area and Severity IndexDupilumabMedicineAtopic dermatitisSCORADDermatology Life Quality IndexQuality of life (healthcare)Adverse effectObservational studyPediatricsInformed consentDermatologyInternal medicineDiseaseAlternative medicinePathologyNursingDermatology and Skin DiseasesAllergic Rhinitis and SensitizationAsthma and respiratory diseases